2014/2759(DEA) | [ParlTrack]

2014/2759(DEA) Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use

Role	Committee	Rapporteur	Shadows
Lead	ENVI

Lead committee dossier: ENVI/8/00856

Subjects

Links

2014/09/17 Committee referral announced in Parliament, 1st reading/single reading
2014/09/16 Initial period for examining delegated act extended at Parliament's request by 2 month(s)
2014/07/17 Initial period for examining delegated act 2 month(s)
2014/05/28 Non-legislative basic document published
- C(2014)03446

(these mark the time of scraping, not the official date of the change)

activities/4	date 2014-11-25T00:00:00 body EP/CSL type Delegated act not objected by Parliament
procedure/stage_reached	Old Awaiting committee decision New Awaiting Council decision on delegated act

activities	date: 2014-05-28T00:00:00 docs: type: Non-legislative basic document published title: C(2014)03446 type: Non-legislative basic document published body: EC commission: date: 2014-07-17T00:00:00 body: EP/CSL type: Initial period for examining delegated act 2 month(s) date: 2014-09-16T00:00:00 body: EP/CSL type: Initial period for examining delegated act extended at Parliament's request by 2 month(s) date: 2014-09-17T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
committees	body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
links
other
procedure	dossier_of_the_committee ENVI/8/00856 reference 2014/2759(DEA) title Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use stage_reached Awaiting committee decision summary Supplementing subtype Examination of delegated act type DEA - Delegated acts procedure subject 4.20.04 Pharmaceutical products and industry